Cargando…

CD39 and LDHA affects the prognostic role of NLR in metastatic melanoma patients treated with immunotherapy

BACKGROUND: Identifying response markers is highly needed to guide the treatment strategy in patients with metastatic melanoma. METHODS: A retrospective study was carried out in patients with unresectable/metastatic melanoma (stage IIIb–IV), treated with anti-PD-1 in the first line setting, to bette...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mallardo, Domenico, Fordellone, Mario, White, Andrew, Ottaviano, Margaret, Sparano, Francesca, Bailey, Michael, Facchini, Arianna Bianca, Ong, Sufey, Maiolino, Piera, Caracò, Corrado, Church, Sarah, Cavalcanti, Ernesta, Warren, Sarah, Budillon, Alfredo, Cesano, Alessandra, Simeone, Ester, Chiodini, Paolo, Ascierto, Paolo Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492378/ https://www.ncbi.nlm.nih.gov/pubmed/37684649 http://dx.doi.org/10.1186/s12967-023-04419-6

Ejemplares similares

Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab
por: Capone, Mariaelena, et al.
Publicado: (2018)

Concomitant medication of cetirizine in advanced melanoma could enhance anti-PD-1 efficacy by promoting M1 macrophages polarization
por: Mallardo, Domenico, et al.
Publicado: (2022)

IL-6 as new prognostic factor in patients with advanced cutaneous squamous cell carcinoma treated with cemiplimab
por: Mallardo, Domenico, et al.
Publicado: (2023)

Nivolumab serum concentration in metastatic melanoma patients could be related to outcome and enhanced immune activity: a gene profiling retrospective analysis
por: Mallardo, Domenico, et al.
Publicado: (2022)

Unsupervised Hierarchical Classification Approach for Imprecise Data in the Breast Cancer Detection
por: Fordellone, Mario, et al.
Publicado: (2022)

A gene expression assay for simultaneous measurement of microsatellite instability and anti-tumor immune activity
por: Danaher, Patrick, et al.
Publicado: (2019)

A monocentric phase I study of vemurafenib plus cobimetinib plus PEG-interferon (VEMUPLINT) in advanced melanoma patients harboring the V600BRAF mutation
por: Simeone, Ester, et al.
Publicado: (2021)

Phase III randomized study of fotemustine and dacarbazine versus dacarbazine with or without interferon-α in advanced malignant melanoma
por: Daponte, Antonio, et al.
Publicado: (2013)

Potential clinical implications of CD4(+)CD26(high) T cells for nivolumab treated melanoma patients
por: Galati, Domenico, et al.
Publicado: (2023)

Modeling for the Stringency of Lock-Down Policies: Effects of Macroeconomic and Healthcare Variables in Response to the COVID-19 Pandemic
por: Santini, Giunio, et al.
Publicado: (2022)

LDHA: The Obstacle to T cell responses against tumor
por: Tang, Yu, et al.
Publicado: (2022)

The role of diabetes in metastatic melanoma patients treated with nivolumab plus relatlimab
por: Mallardo, Domenico, et al.
Publicado: (2023)

Sequencing Targeted and Immune Therapy in BRAF-Mutant Melanoma: Lessons Learned
por: Trojaniello, Claudia, et al.
Publicado: (2023)

Phase 1/2 study of valproic acid and short-course radiotherapy plus capecitabine as preoperative treatment in low-moderate risk rectal cancer-V-shoRT-R3 (Valproic acid - short RadioTherapy - rectum 3rd trial)
por: Avallone, Antonio, et al.
Publicado: (2014)

Novel Peptide Inhibitors for Lactate Dehydrogenase A (LDHA): A Survey to Inhibit LDHA Activity via Disruption of Protein-Protein Interaction
por: Jafary, Farzaneh, et al.
Publicado: (2019)

Inhibition of LDHA suppresses tumor progression in prostate cancer
por: Xian, Zhi-Yong, et al.
Publicado: (2015)

Evaluation of the diagnostic accuracy of a new point-of-care rapid test for SARS-CoV-2 virus detection
por: Miscio, Leonardo, et al.
Publicado: (2020)

NLR-parser: rapid annotation of plant NLR complements
por: Steuernagel, Burkhard, et al.
Publicado: (2015)

Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology
por: Pascarella, Giacomo, et al.
Publicado: (2019)

Long-lasting response to electrochemotherapy in melanoma patients with cutaneous metastasis
por: Caracò, Corrado, et al.
Publicado: (2013)

NLR, d-NLR and PLR can be affected by many factors
por: Bedel, Cihan, et al.
Publicado: (2021)

Use of neoadjuvant electrochemotherapy to treat a large metastatic lesion of the cheek in a patient with melanoma
por: Mozzillo, Nicola, et al.
Publicado: (2012)

LDHA gene is associated with pigeon survivability during racing competitions
por: Ramadan, Sherif, et al.
Publicado: (2018)

LDHA-regulated tumor-macrophage symbiosis promotes glioblastoma progression
por: Khan, Fatima, et al.
Publicado: (2023)

Circulating progastrin-releasing peptide in the diagnosis of Small Cell Lung Cancer (SCLC) and in therapeutic monitoring
por: Barchiesi, Vittoria, et al.
Publicado: (2021)

Early predictors of clinical deterioration in a cohort of outpatients with COVID‐19 in southern Italy: A multicenter observational study
por: Monari, Caterina, et al.
Publicado: (2022)

Correlation between immune-related adverse events and response to pembrolizumab in advanced melanoma patients
por: Grimaldi, Antonio Maria, et al.
Publicado: (2015)

Analysis of T and NK cells immune response in Ipilimumab treated Melanoma patients
por: Tallerico, Rossana, et al.
Publicado: (2015)

NLR and PLR in Schizophrenia
por: Surati, Love, et al.
Publicado: (2022)

Unappreciated Role of LDHA and LDHB to Control Apoptosis and Autophagy in Tumor Cells
por: Urbańska, Kaja, et al.
Publicado: (2019)

LDHA Suppression Altering Metabolism Inhibits Tumor Progress by an Organic Arsenical
por: Liu, Yu-Jiao, et al.
Publicado: (2019)

The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients
por: Yang, Ai-Ping, et al.
Publicado: (2020)

The Predictive Role of NLR, d-NLR, MLR, and SIRI in COVID-19 Mortality
por: Citu, Cosmin, et al.
Publicado: (2022)

Proteomic test for anti-PD-1 checkpoint blockade treatment of metastatic melanoma with and without BRAF mutations
por: Ascierto, Paolo A., et al.
Publicado: (2019)

Dynamic Diversity of NLR Genes in Triticum and Mining of Promising NLR Alleles for Disease Resistance
por: Li, Xiaolong, et al.
Publicado: (2021)

Long-term response after electrochemotherapy in patients with relapsed or refractory cutaneous melanoma
por: Mozzillo, Nicola, et al.
Publicado: (2014)

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme)
por: Avallone, Antonio, et al.
Publicado: (2016)

JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer*
por: Qiu, Haifeng, et al.
Publicado: (2015)

LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis
por: Arra, Manoj, et al.
Publicado: (2020)

Design and Synthesis of New Pyrimidine-Quinolone Hybrids as Novel hLDHA Inhibitors
por: Díaz, Iván, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jr0bq6918vch3251iubvqk8aug